215 related articles for article (PubMed ID: 11860358)
21. Steroid sulfatase: a pivotal player in estrogen synthesis and metabolism.
Purohit A; Woo LW; Potter BV
Mol Cell Endocrinol; 2011 Jul; 340(2):154-60. PubMed ID: 21693170
[TBL] [Abstract][Full Text] [Related]
22. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor.
Stanway SJ; Purohit A; Woo LW; Sufi S; Vigushin D; Ward R; Wilson RH; Stanczyk FZ; Dobbs N; Kulinskaya E; Elliott M; Potter BV; Reed MJ; Coombes RC
Clin Cancer Res; 2006 Mar; 12(5):1585-92. PubMed ID: 16533785
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
[TBL] [Abstract][Full Text] [Related]
24. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
25. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor.
Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ
Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749
[TBL] [Abstract][Full Text] [Related]
26. The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
Day JM; Purohit A; Tutill HJ; Foster PA; Woo LW; Potter BV; Reed MJ
Ann N Y Acad Sci; 2009 Feb; 1155():80-7. PubMed ID: 19250195
[TBL] [Abstract][Full Text] [Related]
27. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells.
MacIndoe JH
Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800
[TBL] [Abstract][Full Text] [Related]
28. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.
Santner SJ; Feil PD; Santen RJ
J Clin Endocrinol Metab; 1984 Jul; 59(1):29-33. PubMed ID: 6725522
[TBL] [Abstract][Full Text] [Related]
29. Sulfamoyloxy-substituted 2-phenylindoles: antiestrogen-based inhibitors of the steroid sulfatase in human breast cancer cells.
Golob T; Liebl R; von Angerer E
Bioorg Med Chem; 2002 Dec; 10(12):3941-53. PubMed ID: 12413846
[TBL] [Abstract][Full Text] [Related]
30. Recent developments of steroid sulfatase inhibitors as anti-cancer agents.
Foster PA; Reed MJ; Purohit A
Anticancer Agents Med Chem; 2008 Oct; 8(7):732-8. PubMed ID: 18855575
[TBL] [Abstract][Full Text] [Related]
31. Stilbene-based inhibitors of estrone sulfatase with a dual mode of action in human breast cancer cells.
Walter G; Liebl R; von Angerer E
Arch Pharm (Weinheim); 2004 Dec; 337(12):634-44. PubMed ID: 15597397
[TBL] [Abstract][Full Text] [Related]
32. Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer.
Palmieri C; Januszewski A; Stanway S; Coombes RC
Expert Rev Anticancer Ther; 2011 Feb; 11(2):179-83. PubMed ID: 21342037
[TBL] [Abstract][Full Text] [Related]
33. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.
Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo models for the evaluation of new inhibitors of human steroid sulfatase, devoid of residual estrogenic activity.
Shields-Botella J; Bonnet P; Duc I; Duranti E; Meschi S; Cardinali S; Prouheze P; Chaigneau AM; Duranti V; Gribaudo S; Rivière A; Mengual L; Carniato D; Cecchet L; Lafay J; Rondot B; Sandri J; Pascal JC; Delansorne R
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):327-35. PubMed ID: 12711019
[TBL] [Abstract][Full Text] [Related]
35. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
Santen RJ
Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
[TBL] [Abstract][Full Text] [Related]
36. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures.
Santner SJ; Ohlsson-Wilhelm B; Santen RJ
Int J Cancer; 1993 Apr; 54(1):119-24. PubMed ID: 8478138
[TBL] [Abstract][Full Text] [Related]
37. Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
Shah R; Singh J; Singh D; Jaggi AS; Singh N
Eur J Med Chem; 2016 May; 114():170-90. PubMed ID: 26974384
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.
Poulin R; Labrie F
Cancer Res; 1986 Oct; 46(10):4933-7. PubMed ID: 2944574
[TBL] [Abstract][Full Text] [Related]
39. In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.
González A; Alvarez-García V; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
Curr Cancer Drug Targets; 2010 May; 10(3):279-86. PubMed ID: 20370689
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens.
Santner SJ; Santen RJ
J Steroid Biochem Mol Biol; 1993 May; 45(5):383-90. PubMed ID: 8388710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
